OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.80
+0.72%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 957.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.61x
- Price / sales
- 345.44x
- Price / cash flow
- -9.98x
Enterprise value
- Enterprise value
- $442.3M
- EV / sales
- 279.43x
- EV / EBITDA
- -12.41x
- EV / EBIT
- -7.58x
- Market cap
- $546.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026